Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
European Lung Foundation
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Researchers in the Netherlands have made a discovery that could be used to develop new drugs to fight tuberculosis (TB).
Scientists have recently discovered that immune cells try to protect the body against TB by breaking down the bacteria when it feels under threat.
In their study, published in the journal, Cell Host & Microbe, the researchers examined this process in zebrafish.
They pinpointed a particular trigger for this immune cell response, a protein called DRAM1. The discovery suggests that the protein could be used to develop new TB drugs in the future.
Read the journal article abstract
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79